FDA Makes It 50 With Accord Trastuzumab Biosimilar Approval

Henlius-Partnered Hercessi Rival To Herceptin Becomes 50th US Biosimilar And First For Accord

Number 50 in red, white and blue
The FDA has approved its 50th biosimilar • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Products

More from Generics Bulletin